SCM Pharma appoints Business Development Director

Simon Bellamy joins the firm with 30 years\' experience in the pharmaceutical industry

UK-based contract development and manufacturing organisation (CDMO) SCM Pharma has strengthened its commercial management team with the appointment of an experienced new director.

Simon Bellamy joins the sterile manufacturing specialist as Business Development Director and will be primarily responsible for bringing in new clinical trials business as well as looking for small commercial opportunities for the company’s new £6m ($10m) facility in Newburn, Tyne-and-Wear.

He brings 30 years’ experience in the pharmaceutical industry to the firm; his most recent business development roles were at Catalent Pharma Solutions and Piramal Healthcare.

Dianne Sharp, SCM Pharma's Managing Director, said: 'Attracting Simon to our business is a major coup given his past experience in the contract manufacturing arena and he will no doubt add a huge amount of value to our exciting growth plans.'

You may also like

Manufacturing

Shire buys assets of SCM Pharma

Confirms that 80 jobs are safeguarded at Northumberland-based company
You need to be a subscriber to read this article.
Click here to find out more.
Manufacturing

HAPI capacity reaches an all-time high

While today’s drugs are more targeted and effective, they bring with them production issues of sterility and higher potency. Susan Birks reports on how the contract manufacturing market has responded to the growing demand for specialist high potency and sterile services
You need to be a subscriber to read this article.
Click here to find out more.
Containment

Handle with care – high potency APIs

Contract manufacturer SCM Pharma, which handles small volume runs of cytotoxic powders and liquids for several clients, outlines the basic containment and cleaning requirements for ensuring worker safety and product purity
Manufacturing

SCM\'s Prudhoe facility gains FDA approval

UK CDMO supports BTG for commercial launch of varicose veins treatment
Manufacturing

SCM Pharma gains MHRA approval for commercial facility

The site will be used for the supply of licensed commercial products and to complement its clinical manufacturing facility
You need to be a subscriber to read this article.
Click here to find out more.
Manufacturing

The changing landscape of clinical trial manufacturing

With regulation changes, the death of the blockbuster, focus on personalised medicines and less R&D spend than ever before, the clinical trial manufacturing landscape has undergone many changes. SCM Pharma’s Dianne Sharp reviews the sector and outlines what companies of the future could look like
Manufacturing

SCM supports BTG in Varisolve scale-up

CDMO has previously been providing clinical development consultancy for varicose vein treatment
Subscribe now